The Plant Derived 3-3′-Diindolylmethane (DIM) Behaves as CB<sub>2</sub> Receptor Agonist in Prostate Cancer Cellular Models

3-3′-Diindolylmethane (DIM) is a biologically active dimer derived from the endogenous conversion of indole-3-carbinol (I3C), a naturally occurring glucosinolate found in many cruciferous vegetables (i.e., <i>Brassicaceae</i>). DIM was the first pure androgen receptor antagonist isolated...

Full description

Bibliographic Details
Main Authors: Paolo Tucci, Iain Brown, Guy S. Bewick, Roger G. Pertwee, Pietro Marini
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/4/3620
_version_ 1797620497493524480
author Paolo Tucci
Iain Brown
Guy S. Bewick
Roger G. Pertwee
Pietro Marini
author_facet Paolo Tucci
Iain Brown
Guy S. Bewick
Roger G. Pertwee
Pietro Marini
author_sort Paolo Tucci
collection DOAJ
description 3-3′-Diindolylmethane (DIM) is a biologically active dimer derived from the endogenous conversion of indole-3-carbinol (I3C), a naturally occurring glucosinolate found in many cruciferous vegetables (i.e., <i>Brassicaceae</i>). DIM was the first pure androgen receptor antagonist isolated from the <i>Brassicaceae</i> family and has been recently investigated for its potential pharmacological use in prostate cancer prevention and treatment. Interestingly, there is evidence that DIM can also interact with cannabinoid receptors. In this context, by considering the well-known involvement of the endocannabinoid system in prostate cancer, we have pharmacologically characterized the properties of DIM on both CB<sub>1</sub> and CB<sub>2</sub> cannabinoid receptors in two human prostate cancer cell lines: PC3 (androgen-independent/androgen receptor negative) and LNCaP (androgen-dependent). In the PC3 cell line, DIM was able to activate CB<sub>2</sub> receptors and potentially associated apoptotic pathways. On the other hand, although DIM was also able to activate CB<sub>2</sub> receptors in the LNCaP cell line, no apoptotic effects were observed. Our evidence confirms that DIM is a CB<sub>2</sub> receptor ligand and, moreover, it has a potential anti-proliferative effect on androgen-independent/androgen receptor-negative prostate cancer cells.
first_indexed 2024-03-11T08:43:22Z
format Article
id doaj.art-d29584426abb446cabf0d52373c3c414
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T08:43:22Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-d29584426abb446cabf0d52373c3c4142023-11-16T21:02:38ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-02-01244362010.3390/ijms24043620The Plant Derived 3-3′-Diindolylmethane (DIM) Behaves as CB<sub>2</sub> Receptor Agonist in Prostate Cancer Cellular ModelsPaolo Tucci0Iain Brown1Guy S. Bewick2Roger G. Pertwee3Pietro Marini4Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, ItalyDivision of Applied Medicine, School of Medicine and Dentistry, Foresterhill, University of Aberdeen, Aberdeen AB25 2ZD, UKThe Institute of Medical Sciences, Foresterhill, University of Aberdeen, Aberdeen AB25 2ZD, UKThe Institute of Medical Sciences, Foresterhill, University of Aberdeen, Aberdeen AB25 2ZD, UKInstitute of Education in Healthcare and Medical Sciences, Foresterhill, University of Aberdeen, Aberdeen AB25 2ZD, UK3-3′-Diindolylmethane (DIM) is a biologically active dimer derived from the endogenous conversion of indole-3-carbinol (I3C), a naturally occurring glucosinolate found in many cruciferous vegetables (i.e., <i>Brassicaceae</i>). DIM was the first pure androgen receptor antagonist isolated from the <i>Brassicaceae</i> family and has been recently investigated for its potential pharmacological use in prostate cancer prevention and treatment. Interestingly, there is evidence that DIM can also interact with cannabinoid receptors. In this context, by considering the well-known involvement of the endocannabinoid system in prostate cancer, we have pharmacologically characterized the properties of DIM on both CB<sub>1</sub> and CB<sub>2</sub> cannabinoid receptors in two human prostate cancer cell lines: PC3 (androgen-independent/androgen receptor negative) and LNCaP (androgen-dependent). In the PC3 cell line, DIM was able to activate CB<sub>2</sub> receptors and potentially associated apoptotic pathways. On the other hand, although DIM was also able to activate CB<sub>2</sub> receptors in the LNCaP cell line, no apoptotic effects were observed. Our evidence confirms that DIM is a CB<sub>2</sub> receptor ligand and, moreover, it has a potential anti-proliferative effect on androgen-independent/androgen receptor-negative prostate cancer cells.https://www.mdpi.com/1422-0067/24/4/3620DIMCB<sub>2</sub> cannabinoid receptorsprostate cancer
spellingShingle Paolo Tucci
Iain Brown
Guy S. Bewick
Roger G. Pertwee
Pietro Marini
The Plant Derived 3-3′-Diindolylmethane (DIM) Behaves as CB<sub>2</sub> Receptor Agonist in Prostate Cancer Cellular Models
International Journal of Molecular Sciences
DIM
CB<sub>2</sub> cannabinoid receptors
prostate cancer
title The Plant Derived 3-3′-Diindolylmethane (DIM) Behaves as CB<sub>2</sub> Receptor Agonist in Prostate Cancer Cellular Models
title_full The Plant Derived 3-3′-Diindolylmethane (DIM) Behaves as CB<sub>2</sub> Receptor Agonist in Prostate Cancer Cellular Models
title_fullStr The Plant Derived 3-3′-Diindolylmethane (DIM) Behaves as CB<sub>2</sub> Receptor Agonist in Prostate Cancer Cellular Models
title_full_unstemmed The Plant Derived 3-3′-Diindolylmethane (DIM) Behaves as CB<sub>2</sub> Receptor Agonist in Prostate Cancer Cellular Models
title_short The Plant Derived 3-3′-Diindolylmethane (DIM) Behaves as CB<sub>2</sub> Receptor Agonist in Prostate Cancer Cellular Models
title_sort plant derived 3 3 diindolylmethane dim behaves as cb sub 2 sub receptor agonist in prostate cancer cellular models
topic DIM
CB<sub>2</sub> cannabinoid receptors
prostate cancer
url https://www.mdpi.com/1422-0067/24/4/3620
work_keys_str_mv AT paolotucci theplantderived33diindolylmethanedimbehavesascbsub2subreceptoragonistinprostatecancercellularmodels
AT iainbrown theplantderived33diindolylmethanedimbehavesascbsub2subreceptoragonistinprostatecancercellularmodels
AT guysbewick theplantderived33diindolylmethanedimbehavesascbsub2subreceptoragonistinprostatecancercellularmodels
AT rogergpertwee theplantderived33diindolylmethanedimbehavesascbsub2subreceptoragonistinprostatecancercellularmodels
AT pietromarini theplantderived33diindolylmethanedimbehavesascbsub2subreceptoragonistinprostatecancercellularmodels
AT paolotucci plantderived33diindolylmethanedimbehavesascbsub2subreceptoragonistinprostatecancercellularmodels
AT iainbrown plantderived33diindolylmethanedimbehavesascbsub2subreceptoragonistinprostatecancercellularmodels
AT guysbewick plantderived33diindolylmethanedimbehavesascbsub2subreceptoragonistinprostatecancercellularmodels
AT rogergpertwee plantderived33diindolylmethanedimbehavesascbsub2subreceptoragonistinprostatecancercellularmodels
AT pietromarini plantderived33diindolylmethanedimbehavesascbsub2subreceptoragonistinprostatecancercellularmodels